These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 7908191

  • 1. Neu and its ligands: from an oncogene to neural factors.
    Peles E, Yarden Y.
    Bioessays; 1993 Dec; 15(12):815-24. PubMed ID: 7908191
    [Abstract] [Full Text] [Related]

  • 2. ErbB kinases and NDF signaling in human prostate cancer cells.
    Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ.
    Oncogene; 1997 Nov 27; 15(22):2705-16. PubMed ID: 9400997
    [Abstract] [Full Text] [Related]

  • 3. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K.
    J Cell Biochem; 1991 Jan 27; 45(1):69-81. PubMed ID: 1706346
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.
    Dougall WC, Qian X, Greene MI.
    J Cell Biochem; 1993 Sep 27; 53(1):61-73. PubMed ID: 7901229
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
    Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R.
    Cancer Res; 1993 Nov 01; 53(21):5251-61. PubMed ID: 8106145
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM, Leder P.
    Oncogene; 1996 Apr 18; 12(8):1781-8. PubMed ID: 8622899
    [Abstract] [Full Text] [Related]

  • 12. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 18; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 13. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y.
    Oncogene; 1998 Mar 12; 16(10):1249-58. PubMed ID: 9546426
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC, Melhem MF, Finley GG, Wen D, Liu N, Deng DH, Salup R.
    Cancer J Sci Am; 1997 Mar 12; 3(1):21-30. PubMed ID: 9072304
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells.
    Sistonen L, Koskinen PJ, Lehväslaiho H, Lehtola L, Bravo R, Alitalo K.
    Oncogene; 1990 Jun 12; 5(6):815-21. PubMed ID: 1972791
    [Abstract] [Full Text] [Related]

  • 18. Similar early gene responses to ligand-activated EGFR and neu tyrosine kinases in NIH3T3 cells.
    Koskinen P, Lehväslaiho H, MacDonald-Bravo H, Alitalo K, Bravo R.
    Oncogene; 1990 Apr 12; 5(4):615-8. PubMed ID: 1970155
    [Abstract] [Full Text] [Related]

  • 19. Role of HER2/neu in tumor progression and therapy.
    Ménard S, Casalini P, Campiglio M, Pupa SM, Tagliabue E.
    Cell Mol Life Sci; 2004 Dec 12; 61(23):2965-78. PubMed ID: 15583858
    [Abstract] [Full Text] [Related]

  • 20. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y, Wada T, Myers JN, Brown VI, Dobashi K, Cohen J, Hamuro J, Weiner DB, Greene MI.
    Princess Takamatsu Symp; 1988 Dec 12; 19():45-57. PubMed ID: 2908355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.